<SEC-DOCUMENT>0001104659-22-085864.txt : 20220804
<SEC-HEADER>0001104659-22-085864.hdr.sgml : 20220804
<ACCEPTANCE-DATETIME>20220804070339
ACCESSION NUMBER:		0001104659-22-085864
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220804
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220804
DATE AS OF CHANGE:		20220804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BICYCLE THERAPEUTICS plc
		CENTRAL INDEX KEY:			0001761612
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38916
		FILM NUMBER:		221134594

	BUSINESS ADDRESS:	
		STREET 1:		BLOCKS A & B, PORTWAY BUILDING
		STREET 2:		GRANTA PARK, GREAT ABINGTON
		CITY:			CAMBRIDGE
		STATE:			X0
		ZIP:			CB21 6GS
		BUSINESS PHONE:		011441223261503

	MAIL ADDRESS:	
		STREET 1:		BLOCKS A & B, PORTWAY BUILDING
		STREET 2:		GRANTA PARK, GREAT ABINGTON
		CITY:			CAMBRIDGE
		STATE:			X0
		ZIP:			CB21 6GS

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BICYCLE THERAPEUTICS Ltd
		DATE OF NAME CHANGE:	20181212
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2222487d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:bcyc="http://bicycletherapeutics.com/20220804">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_bcyc_bicycletherapeutics.com_20220804 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20220804_20220804 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001761612 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_072_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\DocumentInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-08-04to2022-08-04" name="dei:EntityCentralIndexKey">0001761612</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-08-04to2022-08-04" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-08-04to2022-08-04" id="xdx2ixbrl0015" name="dei:EntityTaxIdentificationNumber">00-0000000</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-08-042022-08-04_us-gaap_CommonStockMember" format="ixt:booleantrue" id="xdx2ixbrl0028" name="dei:NoTradingSymbolFlag">true</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="bcyc-20220804.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-08-04to2022-08-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001761612</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-08-04</xbrli:startDate>
        <xbrli:endDate>2022-08-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-08-042022-08-04_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001761612</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-08-04</xbrli:startDate>
        <xbrli:endDate>2022-08-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-08-042022-08-04_custom_AmericanDepositarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001761612</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bcyc:AmericanDepositarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-08-04</xbrli:startDate>
        <xbrli:endDate>2022-08-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br />
SECURITIES AND EXCHANGE COMMISSION<br />
Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_907_edei--DocumentType_c20220804__20220804_zmSSdmR7tJT4"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b>CURRENT REPORT<br />
</b></span><b><span style="font-size: 13pt">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_907_edei--DocumentPeriodEndDate_c20220804__20220804_z5vBTkiLgIP4"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">August 4, 2022</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--EntityRegistrantName_c20220804__20220804_zoqkMlj1P2I9"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" name="dei:EntityRegistrantName">Bicycle Therapeutics plc</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 32%; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_909_edei--EntityIncorporationStateCountryCode_c20220804__20220804_z86gcnfIDndf"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode">England and Wales</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 32%; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90B_edei--EntityFileNumber_c20220804__20220804_zllk7o8WH4cb"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" name="dei:EntityFileNumber">001-38916</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 32%; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_dxL_c20220804__20220804_zQghmKNVV5Q2" title="::XDX::00-0000000"><span style="-sec-ix-hidden: xdx2ixbrl0015">Not applicable</span></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of incorporation)</p></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">File Number)</p></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><span id="xdx_90C_edei--EntityAddressAddressLine1_c20220804__20220804_zYaYyJFvW9fc"><b><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" name="dei:EntityAddressAddressLine1">Blocks
    A &amp; B, Portway Building</ix:nonNumeric></b></span><b>,<br /> <span id="xdx_902_edei--EntityAddressAddressLine2_c20220804__20220804_zn0NRzIod3ia"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" name="dei:EntityAddressAddressLine2">Granta
    Park, Great Abington</ix:nonNumeric></span></b><b>, <span id="xdx_909_edei--EntityAddressCityOrTown_c20220804__20220804_zUWJjmlpzwW5"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" name="dei:EntityAddressCityOrTown">Cambridge</ix:nonNumeric></span></b><b><br /> <span id="xdx_90B_edei--EntityAddressCountry_c20220804__20220804_zzzyxGAvTnte"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">United
    Kingdom</ix:nonNumeric></span></b>

<p style="margin-top: 0; margin-bottom: 0"></p></td>
    <td style="vertical-align: middle; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><b><span id="xdx_90A_edei--EntityAddressPostalZipCode_c20220804__20220804_zVSjCPRWIvb9"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" name="dei:EntityAddressPostalZipCode">CB21
    6GS</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">(Address of principal executive offices)</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">(Zip Code)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Registrant&#8217;s telephone number, including area code: <b><span id="xdx_905_edei--CityAreaCode_c20220804__20220804_zi7vKuj0h858"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" name="dei:CityAreaCode">+44</ix:nonNumeric></span> <span id="xdx_901_edei--LocalPhoneNumber_c20220804__20220804_z0JxvjetFl0l"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" name="dei:LocalPhoneNumber">1223
261503</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Wingdings 2"><span style="font-family: Wingdings"><span id="xdx_90B_edei--WrittenCommunications_c20220804__20220804_zr3kSCme6vX8"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td><td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Wingdings 2"><span style="font-family: Wingdings"><span id="xdx_906_edei--SolicitingMaterial_c20220804__20220804_zrOoeCtNRb56"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td><td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Wingdings 2"><span style="font-family: Wingdings"><span id="xdx_902_edei--PreCommencementTenderOffer_c20220804__20220804_z4QXudP84nKg"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td><td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Wingdings 2"><span style="font-family: Wingdings"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20220804__20220804_zPYQKIrual6c"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td><td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: Black 1pt solid; width: 43%; padding-right: 5.4pt; padding-bottom: 0in; padding-left: 5.4pt; text-align: center; text-indent: 0in"><b>Title of each class</b></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-bottom: 0in; padding-left: 5.4pt; text-align: center; text-indent: 0in"><b>Trading Symbol(s)</b></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 43%; padding-right: 5.4pt; padding-bottom: 0in; padding-left: 5.4pt; text-align: center; text-indent: 0in"><b>Name of each exchange on which registered</b></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: left; text-indent: 0in"><span id="xdx_901_edei--Security12bTitle_c20220804__20220804__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zEZNRkGNRrqa"><ix:nonNumeric contextRef="From2022-08-042022-08-04_us-gaap_CommonStockMember" name="dei:Security12bTitle">Ordinary shares, nominal value &#163;0.01 per share</ix:nonNumeric></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: left; text-indent: 0in"><span id="xdx_909_edei--NoTradingSymbolFlag_dxL_c20220804__20220804__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5bmmTW9F7pa" title="::XDX::true"><span style="-sec-ix-hidden: xdx2ixbrl0028">n/a</span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: left; text-indent: 0in">The<span id="xdx_901_edei--SecurityExchangeName_c20220804__20220804__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1o9W6unow76"> <ix:nonNumeric contextRef="From2022-08-042022-08-04_us-gaap_CommonStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> </span>Stock Market LLC*</td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: left; text-indent: 0in"><span id="xdx_907_edei--Security12bTitle_c20220804__20220804__us-gaap--StatementClassOfStockAxis__custom--AmericanDepositarySharesMember_zPmNTFIU8PId"><ix:nonNumeric contextRef="From2022-08-042022-08-04_custom_AmericanDepositarySharesMember" name="dei:Security12bTitle">American Depositary Shares, each representing one ordinary share, nominal value &#163;0.01 per share</ix:nonNumeric></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: left; text-indent: 0in"><span id="xdx_903_edei--TradingSymbol_c20220804__20220804__us-gaap--StatementClassOfStockAxis__custom--AmericanDepositarySharesMember_zErRWKMf9Twa"><ix:nonNumeric contextRef="From2022-08-042022-08-04_custom_AmericanDepositarySharesMember" name="dei:TradingSymbol">BCYC</ix:nonNumeric></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: left; text-indent: 0in">The<span id="xdx_907_edei--SecurityExchangeName_c20220804__20220804__us-gaap--StatementClassOfStockAxis__custom--AmericanDepositarySharesMember_z5jxu7elYbWl"> <ix:nonNumeric contextRef="From2022-08-042022-08-04_custom_AmericanDepositarySharesMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> </span>Stock Market LLC</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.35pt"><b>* </b>Not for trading, but only in connection
with the listing of the American Depositary Shares on The Nasdaq Stock Market LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or
Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 27.35pt">Emerging growth company&#160;&#160;&#160;&#160;<span style="font-family: Wingdings"><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20220804__20220804_zmWvf8ktMifa"><ix:nonNumeric contextRef="From2022-08-04to2022-08-04" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.35pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.35pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.35pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.35pt">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white; color: #333333">
  <tr style="vertical-align: top">
    <td style="width: 1in"><span style="font-size: 10pt"><b>Item&#160;2.02.</b></span></td>
    <td><span style="font-size: 10pt"><b>Results of Operations and Financial Condition</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 4, 2022, Bicycle Therapeutics plc (the &#8220;Company&#8221;)
issued a press release announcing financial results for the fiscal quarter ended June 30, 2022 and other business highlights. A copy of
the press release is being furnished as Exhibit&#160;99.1 to this Current Report on Form&#160;8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information contained in Item 2.02 in this Current Report on Form&#160;8-K
(including Exhibit&#160;99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of
1934 (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference
in such a filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white; color: #333333"><tr style="vertical-align: top">
<td style="width: 1in"><b>Item 8.01</b></td><td><b>Other Events</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #333333">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #333333">Also on August 4, 2022, the
Company posted an updated corporate presentation on the Company&#8217;s website. To access the presentation, investors should visit the
&#8220;Presentation and Events&#8221; section of the Company&#8217;s website at investors.bicycletherapeutics.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #333333">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #333333">The information furnished
under this Item 8.01 shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as
amended, or subject to the liabilities of that section. The information shall not be deemed incorporated by reference into any other filing
with the&#160;Securities and Exchange Commission&#160;made by the Company, regardless of any general incorporation language in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #333333">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white; color: #333333"><tr style="vertical-align: top">
<td style="width: 1in"><b>Item 9.01</b></td><td><b>Financial Statements and Exhibits</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #333333">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #333333">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #333333">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 18%"><span style="font-size: 10pt; color: #333333"><b>Exhibit No.</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 81%; text-align: center"><span style="font-size: 10pt; color: #333333"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2222487d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">99.1</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2222487d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Press Release issued August 4, 2022 regarding financial results and business highlights</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cover Page Interactive Data File (embedded within the Inline XBRL
document)&#160;</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #333333">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td><span style="font-size: 10pt">Date: August 4, 2022</span></td>
  <td colspan="2"><span style="font-size: 10pt; font-variant: small-caps"><b>Bicycle Therapeutics plc</b></span></td></tr>
<tr style="vertical-align: top">
  <td>&#160;</td>
  <td colspan="2">&#160;</td></tr>

<tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt; width: 50%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%">By:</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">/s/ Lee Kalowski</td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Name:</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Lee Kalowski</td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Title:</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Chief Financial Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.35pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.35pt"></p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx9jtFKwzAUhp+g73DI9djSDFF7V6sOsROpQwTxIrZnGmxyykk23SP5lqYpY3eGQAj/95/vCDETK7o1PTK8XDU1bNAOvQ4IDW6R0bUYieruvoD4NvhhfGDtQvoeixXFDsbO2TxXOgYJ3RuPXQFSLdTFQimQ58XyEsq1yMa8Irc1HbpgdA/adfDINLDBoPkwTdjoH3JkD0n1jOwNuQLyuZziX1AyV/BAe/1N/OWhriuRzdLJxIppN4yanQ9k4aZHG11+qp5uWqVNTFFaZNNqd40DeTPu8fSpGf0a7Tty5KRUS5mXo//IwgmGif43hNdp2NtR/wdJFHOm -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2222487d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.25pt"><IMG SRC="tm2222487d1_ex99-1imag01.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B>Bicycle Therapeutics Reports Second Quarter 2022
Financial Results and Provides Corporate Update</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">-&nbsp;&nbsp;&nbsp;&nbsp;<I>Continued clinical progress across pipeline, including
dosing of the first patient in expansion</I></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>cohorts of Phase I/II study of BT5528</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><I>&nbsp;</I></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">-&nbsp;&nbsp;&nbsp;&nbsp;<I>Expansion of Genentech
exclusive strategic collaboration, triggering a $10 million payment to</I></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>Bicycle in Q3</I></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- &nbsp;&nbsp;&nbsp;&nbsp;<I>Cash and cash equivalents of
$372.8 million as of June 30, 2022, excludes $9.8 million UK R&amp;D <BR>
tax credit received in July and Genentech payment; expected financial
runway into 2025</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CAMBRIDGE,
England, &amp; BOSTON, August 4, 2022 </B></FONT>&ndash; Bicycle Therapeutics <FONT STYLE="font-size: 10pt">plc </FONT>(NASDAQ: BCYC),
a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (<I>Bicycle&reg;</I>)
technology, today reported financial results for the second quarter ended June 30, 2022 and provided recent corporate updates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&ldquo;We are pleased with the progress
of our wholly owned clinical oncology pipeline of <I>Bicycle </I>Toxin Conjugate, or BTC&trade;, programs and <I>Bicycle </I>tumor-targeted
immune cell agonist&reg;, or <I>Bicycle </I>TICA&trade;, programs,&rdquo; said Kevin Lee, Ph.D., Chief Executive Officer of Bicycle Therapeutics.
 &ldquo;In the second quarter, we initiated the expansion cohorts of our Phase I/II study of BT5528, and development of BT8009 and BT7480
remains on track as these programs advance in their respective clinical trials.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&ldquo;In addition,
we were delighted to announce the second expansion of our immuno-oncology collaboration with Genentech last month, highlighting the potential
of the platform beyond our BTCs and <I>Bicycle</I> TICAs,&rdquo; Dr Lee continued. &ldquo;We are pleased to have a strong balance sheet
which helps support the advancement of our programs and which we anticipate provides a financial runway into 2025.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Second Quarter 2022 and Recent
Highlights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23.95pt"></TD><TD STYLE="width: 18.05pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Announced First Patient Dosed in the Expansion Cohorts of Phase I/II Trial of
BT5528. </B>In June 2022, Bicycle announced that the first patient was dosed in the expansion cohorts of the Phase I/II study of BT5528,
Bicycle&rsquo;s second-generation <I>Bicycle</I> Toxin Conjugate (BTC&trade;) targeting EphA2. Up to 56 patients will be enrolled in the
initial expansion cohorts, with the ability to further expand enrollment based on the results from these cohorts. Bicycle intends to provide
completed results of the dose escalation portion of the clinical trial during the third quarter of 2022.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 23.95pt"></TD><TD STYLE="width: 18.05pt; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Announced Expansion of Genentech Immuno-Oncology Collaboration.
</B>In July 2022, Bicycle announced that Genentech exercised an option to initiate a new program, expanding the exclusive strategic collaboration
agreement with Bicycle to discover, develop and commercialize novel <I>Bicycle</I>&reg;-based immuno-oncology therapies. This expansion
represented the second option exercised by Genentech under the terms of the original February 2020 agreement and triggered a $10 million
payment to Bicycle, which is expected to be received in the third quarter of 2022.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.9pt 0pt 42pt; text-align: justify; text-indent: -18.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.9pt 0pt 42pt; text-align: justify; text-indent: -18.05pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.9pt 0pt 42pt; text-align: justify; text-indent: -18.05pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 23.95pt"></TD><TD STYLE="width: 18.05pt; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Presented Trials in Progress Poster Featuring BT7480 Phase
I/II Clinical Trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. </B>In June 2022, Bicycle presented a Trials
in Progress poster highlighting the Phase I/II clinical trial of BT7480, a novel, fully synthetic <I>Bicycle </I>TICA&trade; targeting
Nectin-4 and agonizing CD137.</TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 23.95pt"></TD><TD STYLE="text-align: justify; width: 18.05pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Announced Interim BT8009 Phase I Clinical Trial Results at the 2022 American
Association for Cancer Research (AACR) Annual Meeting.</B> In April 2022, Bicycle announced interim Phase I results from the Phase I/II
trial of BT8009, a second-generation BTC&trade; targeting Nectin-4. As of March 7, 2022, 37 patients have been dosed in the Phase I/II
trial of BT8009. A total of 12 response evaluable urothelial cancer (UC) patients have been dosed in monotherapy cohorts of 2.5mg/m<SUP>2</SUP>
and 5.0mg/m<SUP>2</SUP> weekly in the ongoing trial. Four response evaluable UC patients were dosed at 2.5mg/m<SUP>2</SUP> weekly, with
one patient observed to have tumor reductions constituting a confirmed partial response (PR) and two patients observed to have stable
disease (SD). Eight response evaluable UC patients were dosed at 5.0mg/m<SUP>2</SUP> weekly, with four patients observed to have a confirmed
complete response (CR) or PR, including one patient with a CR and three patients with a PR, and two patients with SD, reflecting a 50%
overall response rate and 75% disease control rate. As of March 7, 2022, the median duration of response had not yet been reached in either
the 2.5 mg/m<SUP>2</SUP> or 5.0mg/m<SUP>2</SUP> cohort, with four of the five responders in these cohorts still on therapy after at least
24 weeks.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt">Exploration of additional doses and frequencies continues,
and Bicycle intends to provide further updates this year.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt"><B>Financial Results</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 23.95pt"></TD><TD STYLE="text-align: justify; width: 18.05pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">Cash and cash equivalents were $372.8 million as of June 30, 2022, compared to $438.7 million as of December
31, 2021. The decrease in cash is primarily due to cash used in operating activities.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 23.95pt"></TD><TD STYLE="text-align: justify; width: 18.05pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">Research and development expenses were $19.9 million for the three months ended June 30, 2022, compared
to $11.7 million for the three months ended June 30, 2021. The increase in expense of $8.2 million was primarily due to increased clinical
program expenses for BT5528 and BT8009, <I>Bicycle </I>TICA program development expenses, as well as increased personnel-related expenses,
including $1.6 million of incremental non-cash share-based compensation expenses, and increased facilities-related expenses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 23.95pt"></TD><TD STYLE="text-align: justify; width: 18.05pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">General and administrative expenses were $11.8 million for the three months ended June 30, 2022, compared
to $7.3 million for the three months ended June 30, 2021. The increase of $4.5 million for the three months ended June 30, 2022 as compared
to the same period in the prior year was primarily due to an increase in personnel-related expenses, including $1.5 million of incremental
non-cash share-based compensation expense, and an unfavorable effect of foreign exchange rates.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 23.95pt"></TD><TD STYLE="text-align: justify; width: 18.05pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">Net loss was $26.8 million, or $(0.90) basic and diluted net loss per share, for the three months ended
June 30, 2022, compared to net loss of $17.9 million, or $(0.74) basic and diluted net loss per share, for the three months ended June
30, 2021.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>About Bicycle Therapeutics</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage
biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing
therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize
their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive
candidates for drug development. Bicycle is evaluating BT5528, a second-generation <I>Bicycle </I>Toxin Conjugate (BTC&trade;) targeting
EphA2; BT8009, a second-generation BTC targeting Nectin-4, a well-validated tumor antigen; and BT7480, a <I>Bicycle </I>TICA&trade; targeting
Nectin-4 and agonizing CD137, in company-sponsored Phase I/II trials. In addition, BT1718, a BTC that targets MT1- MMP, is being investigated
in an ongoing Phase I/IIa clinical trial sponsored by the Cancer Research UK Centre for Drug Development. Bicycle is headquartered in
Cambridge, UK, with many key functions and members of its leadership team located in Lexington, Massachusetts. For more information,
visit <U>bicycletherapeutics.com.</U></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Forward Looking Statements</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">This press release may contain forward-looking
statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may
be identified by words such as &ldquo;aims,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;could,&rdquo;
 &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo; &ldquo;forecasts,&rdquo; &ldquo;goal,&rdquo; &ldquo;intends,&rdquo;
 &ldquo;may,&rdquo; &ldquo;plans,&rdquo; &ldquo;possible,&rdquo; &ldquo;potential,&rdquo; &ldquo;seeks,&rdquo; &ldquo;will&rdquo; and
variations of these words or similar expressions that are intended to identify forward-looking statements, although not all
forward-looking statements contain these words. Forward-looking statements in this press release include, but are not limited to,
statements regarding Bicycle&rsquo;s anticipated advancement of its product candidates, including BT5528, BT8009 and BT7480; the
anticipated dosing in and progression of Bicycle&rsquo;s clinical trials; the availability of data from clinical trials; the
therapeutic potential for <I>Bicycles </I>in oncology and other applications; Bicycle&rsquo;s plans to expand its discovery efforts
and early development pipeline; and Bicycle&rsquo;s expected financial runway. Bicycle may not actually achieve the plans,
intentions or expectations disclosed in these forward-looking statements, and you should not place undue reliance on these
forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed
in these forward-looking statements as a result of various factors, including: risks to clinical trial site initiation, patient
enrollment and follow-up, as well as to Bicycle&rsquo;s abilities to meet other anticipated deadlines and milestones, presented by
the ongoing COVID-19 pandemic; uncertainties inherent in the initiation and completion of clinical trials and clinical development
of Bicycle&rsquo;s product candidates; the risk that Bicycle may not realize the intended benefits of its technology; availability
and timing of results from clinical trials; whether the outcomes of preclinical studies will be predictive of clinical trial
results; whether initial or interim results from a clinical trial will be predictive of the final results of the trial or the
results of future trials; the risk that trials may be delayed and may not have satisfactory outcomes; potential adverse effects
arising from the testing or use of Bicycle&rsquo;s product candidates; the risk that Bicycle&rsquo;s projections regarding its
expected financial runway are inaccurate or that its conduct of its business requires more cash than anticipated; and other
important factors, any of which could cause Bicycle&rsquo;s actual results to differ from those contained in the forward-looking
statements, are described in greater detail in the section entitled &ldquo;Risk Factors&rdquo; in Bicycle&rsquo;s Quarterly Report
on Form 10-Q filed with the Securities and Exchange Commission (SEC) on May 5, 2022, as well as in other filings Bicycle may make
with the SEC in the future. Any forward-looking statements contained in this press release speak only as of the date hereof, and
Bicycle expressly disclaims any obligation to update any forward-looking statements contained herein, whether because of any new
information, future events, changed circumstances or otherwise, except as otherwise required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.35pt 0pt 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.35pt 0pt 6pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.35pt 0pt 6pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 64.7pt 0pt 64.65pt; text-align: center"><B>Bicycle Therapeutics plc</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 64.7pt 0pt 64.65pt; text-align: center"><B>Condensed Consolidated Statements
of Operations and Comprehensive Loss</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 64.7pt 0pt 64.65pt; text-align: center"><B>(In thousands, except share and per share data)</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 64.7pt 0pt 64.65pt; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.35pt 0pt 6pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD COLSPAN="7" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Three Months Ended</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif">Six Months Ended</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">June 30,</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">June 30,</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">2022</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">2021</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">2022</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">2021</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font: 10pt Times New Roman, Times, Serif; text-align: left">Collaboration revenues</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">4,378</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">1,785</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">8,238</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">3,593</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating expenses:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 6pt">Research and development</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">19,854</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11,722</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">34,138</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">21,415</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 6pt">General and administrative</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">11,824</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,340</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">28,783</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15,479</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 12pt">Total operating expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">31,678</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">19,062</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">62,921</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">36,894</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Loss from operations</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(27,300</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(17,277</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(54,683</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(33,301</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other income (expense):</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 6pt">Interest income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">908</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">23</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,126</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">38</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 6pt">Interest expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(883</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(819</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,701</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,341</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 12pt">Total other income (expense), net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">25</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(796</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(575</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,303</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss before income tax provision</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(27,275</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(18,073</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(55,258</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(34,604</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 6pt">Benefit from income taxes</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(447</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(160</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(866</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(500</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(26,828</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(17,913</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(54,392</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(34,104</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss per share, basic and diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.90</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.74</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(1.84</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(1.48</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Weighted average ordinary shares outstanding, basic and d<FONT STYLE="font-style: normal; font-weight: normal">iluted</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><FONT STYLE="font-style: normal; font-weight: normal">29,648,564</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><FONT STYLE="font-style: normal; font-weight: normal">24,052,168</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><FONT STYLE="font-style: normal; font-weight: normal">29,626,974</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><FONT STYLE="font-style: normal; font-weight: normal">23,047,745</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 193.6pt; text-align: center"><B>Balance Sheets Data</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 193.6pt; text-align: center"><B>(In thousands)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 193.6pt; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 193.6pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif">June 30,</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif">December 31,</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">2022</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">2021</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font: 10pt Times New Roman, Times, Serif; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">372,769</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">438,680</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Working capital</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">367,152</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">422,317</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">445,482</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">479,792</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total shareholders&rsquo; equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">311,392</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">346,254</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Investors:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">David Borah, CFA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">VP, Capital Markets &amp; Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><U>david.borah@bicycletx.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">617 203-8300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Media:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Argot Partners</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Sarah Sutton</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><U>bicycle@argotpartners.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">212-600-1902</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>bcyc-20220804.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaSN2bOdzZR+OYkxtmB+bdkKfykpcZa4Riln8xZ24S8A -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:bcyc="http://bicycletherapeutics.com/20220804" elementFormDefault="qualified" targetNamespace="http://bicycletherapeutics.com/20220804">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://bicycletherapeutics.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="bcyc-20220804_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="bcyc-20220804_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="bcyc-20220804_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="bcyc_AmericanDepositarySharesMember" name="AmericanDepositarySharesMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>bcyc-20220804_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bicycletherapeutics.com/role/Cover" xlink:href="bcyc-20220804.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bicycletherapeutics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="bcyc-20220804.xsd#bcyc_AmericanDepositarySharesMember" xlink:label="loc_bcycAmericanDepositarySharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_bcycAmericanDepositarySharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>bcyc-20220804_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="bcyc-20220804.xsd#bcyc_AmericanDepositarySharesMember" xlink:label="bcyc_AmericanDepositarySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bcyc_AmericanDepositarySharesMember" xlink:to="bcyc_AmericanDepositarySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bcyc_AmericanDepositarySharesMember_lbl" xml:lang="en-US">American Depositary Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bcyc_AmericanDepositarySharesMember" xlink:to="bcyc_AmericanDepositarySharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bcyc_AmericanDepositarySharesMember_doc" xml:lang="en-US">American Depositary Shares</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>bcyc-20220804_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bicycletherapeutics.com/role/Cover" xlink:href="bcyc-20220804.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://bicycletherapeutics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bcyc-20220804.xsd#bcyc_AmericanDepositarySharesMember" xlink:label="loc_bcycAmericanDepositarySharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_bcycAmericanDepositarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2222487d1_ex99-1imag01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2222487d1_ex99-1imag01.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "! 2P# 2(  A$! Q$!_\0
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MUPN+R;]MKXC1S7UY-"?@+<R"&68RQJRZQ90)L20,B%8(8HR\:1R/L!9L,ZL
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M>9#+!-$[QRQR1E71U8JR.K*2K GY9_;GU;5/#W[%W[7^OZ'J-YHVLZ+^S/\
M'#5]*U;3KBXMM1TW4]-^&/B:[T_4+"XMIK6:VO+*Z@AN;::*=72:-6#+CF0/
MJXD @$@$Y(!(!(&,D?3(SZ9'K0&4]&4_0@U_$Q_P;0?'CXW?%7]J[XYZ/\3O
MBY\1/B'I.G?!BUO].T[QAXHU37;*QOY/%%O$]_;6^I75WY-U);B.!W27[B
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M->=>//V /A%K]C._A&]UOP;JBJ6MV26'4=))&"(WT^6VRB.!L+1,77=O57<
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MQ-XEN8;V*.UM=.BMK'3VOIIGDE%W->2W-Y(L,@B\]HHW9>&3(;=]VQ+LCC0
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M5'^%.HJ53@E90@EV4():[Z*"6O737K<$[;:>FF^^UM^O<0*HZ*H^@ H"J,D
M GJ0 ,_7'6EHJWK:^MMKZVZ:7O;332VFFPDDMDEZ)+\D@HH.<' R<<#.,GTS
MSCZXJ-I IP5;JHSE0,L">"S*#C R 2W/ (R0#)**122.1@]QU'X' R/?%+0
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M8K2:[TRP9["*XFDQ%'')?-;12!F#O"\J1AB3@ [+QE\5OAK\/;BVM_'?Q(\
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M@,JDJ" 2*T+>TM;2&.WM+:WM8(5"0P6\,<$,2 $!8XXE5(U ) 55  ) ')H
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M_P""1G[27PH^!?PEM?V&?C#XA?X;_M->!?C[\;O"C_#7Q9I>I:5JWBA/$'Q
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8B@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140417783672320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 04, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  04,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Bicycle Therapeutics plc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001761612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">X0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Blocks
    A & B, Portway Building<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Granta
    Park, Great Abington<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">GB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">CB21
    6GS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">1223
261503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, nominal value &#163;0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_NoTradingSymbolFlag', window );">No Trading Symbol Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bcyc_AmericanDepositarySharesMember', window );">American Depositary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing one ordinary share, nominal value &#163;0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BCYC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoTradingSymbolFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a security having no trading symbol.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoTradingSymbolFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:trueItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bcyc_AmericanDepositarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bcyc_AmericanDepositarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>tm2222487d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bcyc="http://bicycletherapeutics.com/20220804"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bcyc-20220804.xsd" xlink:type="simple"/>
    <context id="From2022-08-04to2022-08-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001761612</identifier>
        </entity>
        <period>
            <startDate>2022-08-04</startDate>
            <endDate>2022-08-04</endDate>
        </period>
    </context>
    <context id="From2022-08-042022-08-04_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001761612</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-04</startDate>
            <endDate>2022-08-04</endDate>
        </period>
    </context>
    <context id="From2022-08-042022-08-04_custom_AmericanDepositarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001761612</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bcyc:AmericanDepositarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-04</startDate>
            <endDate>2022-08-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-08-04to2022-08-04">0001761612</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-08-04to2022-08-04">false</dei:AmendmentFlag>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-08-04to2022-08-04" id="xdx2ixbrl0015">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:NoTradingSymbolFlag
      contextRef="From2022-08-042022-08-04_us-gaap_CommonStockMember"
      id="xdx2ixbrl0028">true</dei:NoTradingSymbolFlag>
    <dei:DocumentType contextRef="From2022-08-04to2022-08-04">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-08-04to2022-08-04">2022-08-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-08-04to2022-08-04">Bicycle Therapeutics plc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-08-04to2022-08-04">X0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-08-04to2022-08-04">001-38916</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-08-04to2022-08-04">Blocks     A &amp; B, Portway Building</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-08-04to2022-08-04">Granta     Park, Great Abington</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-08-04to2022-08-04">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2022-08-04to2022-08-04">GB</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="From2022-08-04to2022-08-04">CB21     6GS</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-08-04to2022-08-04">+44</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-08-04to2022-08-04">1223 261503</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-08-04to2022-08-04">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-08-04to2022-08-04">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-08-04to2022-08-04">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-08-04to2022-08-04">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-08-042022-08-04_us-gaap_CommonStockMember">Ordinary shares, nominal value &#xa3;0.01 per share</dei:Security12bTitle>
    <dei:SecurityExchangeName contextRef="From2022-08-042022-08-04_us-gaap_CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-08-042022-08-04_custom_AmericanDepositarySharesMember">American Depositary Shares, each representing one ordinary share, nominal value &#xa3;0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-08-042022-08-04_custom_AmericanDepositarySharesMember">BCYC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-08-042022-08-04_custom_AmericanDepositarySharesMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-08-04to2022-08-04">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " !R. 15!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( '(X!%7%D[V#[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( '(X!%697)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M<C@$50SF(G/K!   *Q0  !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( '(X!%7@]#J)J@(  # ,   -
M          "  2X-  !X;"]S='EL97,N>&UL4$L! A0#%     @ <C@$59>*
MNQS     $P(   L              ( ! Q   %]R96QS+RYR96QS4$L! A0#
M%     @ <C@$5:K$(A8S 0  (@(   \              ( ![!   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( '(X!%4D'INBK0   /@!   :
M      "  4P2  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( '(X!%5ED'F2&0$  ,\#   3              "  3$3  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  'L4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2222487d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bicycletherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2222487d1_8k.htm">tm2222487d1_8k.htm</File>
    <File>bcyc-20220804.xsd</File>
    <File>bcyc-20220804_def.xml</File>
    <File>bcyc-20220804_lab.xml</File>
    <File>bcyc-20220804_pre.xml</File>
    <File>tm2222487d1_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2222487d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "bcyc-20220804_def.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2222487d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bcyc-20220804_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bcyc-20220804_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bcyc-20220804.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 65,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 1,
   "memberStandard": 1,
   "nsprefix": "bcyc",
   "nsuri": "http://bicycletherapeutics.com/20220804",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2222487d1_8k.htm",
      "contextRef": "From2022-08-04to2022-08-04",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://bicycletherapeutics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2222487d1_8k.htm",
      "contextRef": "From2022-08-04to2022-08-04",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "bcyc_AmericanDepositarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares",
        "label": "American Depositary Shares [Member]"
       }
      }
     },
     "localname": "AmericanDepositarySharesMember",
     "nsuri": "http://bicycletherapeutics.com/20220804",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://bicycletherapeutics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001104659-22-085864-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-22-085864-xbrl.zip
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M' */W\B@\8.,0F58<;?,&TV?6;JF\OT6ZL6%MAX*T+FE![#9I,80!42+W1E
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M="4^B<WE)O'7'&=$;/D_4$L#!!0    ( '(X!%5]/.T5.P@   AD   5
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M.:(I/DH)YV\R;</6P2[H  A5O DSCRLYHBE^F5(UM?W?6R479E:L\PTI[RD
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M,C(R,C0X-V0Q7SAK+FAT;>T]:5/B2M??K?(_],.MN>4\(TM8%-#A*01U&!U
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MA*)%?'$>$A Q]2NS$ )]F,^Q)V !CS\PP"-*UX#K1+=-D_90V.!YC?B@M0<
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MDO"+$,/S?2--BAQ[8*;M"-,M;K5*I;:X<W;?K+5*H(39B'++0XF#=>O?T##
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MAJ>5(OGJH%ZJ-T*P/5"C8/U[ *[E@GJ-P ?O0!A:,[T.+79L:(^;W!_CF/W
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M_0#_URIS_!EUD0.B<(9"9&XW6P9:!Y((AG\5"F"1F6E\ I,\8$<PT?> @50
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M]&]O#-897"Q1FDMN<XBZP#SQSG2MS\-,9;C10>7%7<JML-O>&V'>=F2;3 \
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ME=C" 1PR\!%%5R#U5!\&'O.Q0_,S0 B41(<?I8FJ%O\'[G&?''\]D5N1V(1
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MHFJ&Z%="]+L2G\IK4A5#S?<H.J^-Y'*&Y(R3?PHDOPDG+VT 8 D \L"U \O
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M4$L! A0#%     @ <C@$57T\[14["   "&0  !4              ( !7QD
M &)C>6,M,C R,C X,#1?<')E+GAM;%!+ 0(4 Q0    ( '(X!%6<1@O 0!8
M ,-[   2              "  <TA  !T;3(R,C(T.#=D,5\X:RYH=&U02P$"
M% ,4    " !R. 15%L#>N80;  #,X   %@              @ $].   =&TR
I,C(R-#@W9#%?97@Y.2TQ+FAT;5!+!08     !@ & (P!  #U4P     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
